Results 271 to 280 of about 115,341 (318)

Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial [PDF]

Jing Wu, Shilong Zhang, Shan Yu, Guo An, Yì Wáng, Yiyi Yu, Li Liang, Yan Wang, xiaojing xu, Ying Xiong, Ди Шао, Zhun Shi, Nannan Li, Jingyuan Wang, Da-Wei Jin, Tianshu Liu, Yuehong Cui   +16 more
openalex   +1 more source

The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma. [PDF]

Sci Rep
Schleussner N, Knipper K, Leugner E, Goddemeier C, Yasar U, Wirsik NM, Jung JO, Fuchs HF, Schiffmann LM, Quaas A, Bruns CJ, Schmidt T.   +11 more
europepmc   +1 more source

Cutaneous metastases from esophageal adenocarcinoma: Taking clues from dermoscopy. [PDF]

JAAD Case Rep
Patrick B, Beck AT, Ballenger A.
europepmc   +1 more source

The Proportion of Esophageal Adenocarcinoma Patients With Prior Barrett's Esophagus: Results From a Large Population Based Cohort

, 2011
Shivaram Bhat, Helen G. Mulholland, Damian McManus, Anna Gavin, Liam Murray, Brian Johnston   +5 more
openalex   +1 more source

Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett's esophagus. [PDF]

Dis Esophagus
Vissapragada R, Bulamu NB, Whiteman DC, Bright T, Karnon J, Watson DI.   +5 more
europepmc   +1 more source

Case Report: Tislelizumab-induced delayed-onset diabetic ketoacidosis and hypothyroidism in esophageal adenocarcinoma. [PDF]

Front Oncol
Li Z, Han K, Li L, Han X, Zhang F, Guo L.   +5 more
europepmc   +1 more source

Artificial neural networks as a prognostic tool using hyperspectral imaging on pretherapeutic histopathological specimens of esophageal adenocarcinoma. [PDF]

J Cancer Res Clin Oncol
Trifone CT, Maktabi M, Bischoff P, Schierle K, Niebisch S, Moulla Y, Plum PS, Jansen-Winkeln B, Gockel I, Thieme R.   +9 more
europepmc   +1 more source

Integrative GEO and Mendelian randomization analysis reveals transcriptomic and lipidomic features of esophageal adenocarcinoma. [PDF]

Medicine (Baltimore)
Wang Y, Liu H.
europepmc   +1 more source

Risk of Barrett's esophagus progression to esophageal adenocarcinoma. [PDF]

Clin Endosc
Kota L, Tyberg A.
europepmc   +1 more source

Circulating free DNA as a predictive biomarker for response to nivolumab and platinum-based chemotherapy in metastatic esophageal adenocarcinoma: a prospective pilot study. [PDF]

Front Oncol
Du QS, Fan B.
europepmc   +1 more source